2021 Emerging Topic Conference: Chronic Hepatitis B: From Population to New Molecules and Back
Image For Activity Cover
4 Courses
Credit Offered
7 AMA PRA Category 1 Credits
7 ABIM MOC Points
  • Description:
  • Learning Objectives:
  • Target Audience
  • Credit Designation
  • Recommended

This conference will provide a comprehensive and in-depth discussion of the most updated treatment strategies as well as data/care gap to prevent and manage the HBV population. A review of the preclinical and clinical frontiers of HBV cure molecules after a state-of-the-art review of novel molecular and immunologic HBV cure markers will be covered along with an assessment of HBV cure’s impact on HBV epidemiology and population health.

Online presentations comprised of PowerPoint slides and accompanying audio, evaluations, and continuing education credit claiming:
- 19 online, narrated presentations 20 minutes in length 
- Evaluation for CME credit/ABIM MOC point offerings 

Review all section tabs before you begin. Start watching the presentation videos. Complete necessary components to claim either CME and ABIM and or ABP MOC.

Member —  $175
Trainee & Assoc. Members — $100
Student Member —  $50
Non-Member —  $225
Any physician, scientist, or researcher with doctoral-level training who is not employed by Industry (pharma/device/etc.)
Trainee & Assoc. Non-Member —  $150
Any physician, scientist or researcher in a training program as certified by the director of their training program. This category also includes, but is not limited to, the degrees of MS, NP, PA, RN, and other related or comparable degrees.
Student Non-Member —  $75
Industry —  $450
Any Industry (pharma/device/etc.) employee with or without medical training.
Patient / Patient Advocate — Free

CANCELLATION POLICY (Ended March 11,2021

- Requests for cancellations must be submitted in writing to meetings@aasld.org.
- Cancellations received through March 11, 2021 at 11:59 pm ET are subject to a 20% cancellation fee.
- Cancellations received on March 12, 2021 and after are non-refundable.

Continuing Medical Education (CME): 7.00 AMA PRA Category 1 Credits™
ABIM Maintenance of Certification (MOC): 7.00 ABIM MOC Points

To claim both CME Credits and ABIM MOC points for this activity you must:  

             o    Watch each video presentation
             o    Complete the Final Evaluation
             o    Claim CME credits (ABIM Rule: MOC points must be equivalent to the amount of CME credits claimed for the activity.)

MOC completions are collected on the 15th of each month and submitted to the ABIM by the last day of the month. Points are not submitted automatically and will not display immediately on your ABIM MOC Profile.
MOC points are available for ABIM  board certified physicians only.

Live Program Release Date: March 12, 2021
Live Program Expiration Date: March 14, 2021

Enduring Activity Release Date: May 17, 2021
Enduring Activity Expiration Date: May 14, 2024

Purchase Activity by: December 31, 2021

All faculty in this activity have given their permission for publication ©2021 AASLD. 

Upon completion of this activity, learners will be able to:

• Identify populations to screen for HBV, to vaccinate, and to treat with focus on groups with controversial treatment indications.
• Interpret results of new molecular and immunologic HBV cure biomarkers and learn about most updated HBV cure therapeutic development.
• Detect areas of data gaps for future epidemiological, clinical, and translational research

This activity was planned in the context of the following ACGME/IOM/IPEC competencies: Patient Care and Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Interpersonal and Communication Skills, Professionalism, Systems-based Practice, Provide Patient-centered Care, Work in Interdisciplinary Teams, Employ Evidence-based Practice, Apply Quality Improvement, Utilize Informatics, Values/Ethics for Interprofessional Practice, Roles/Responsibilities, Interprofessional Communication, Teams and Teamwork 

• Hepatologists
• Gastroenterologists
• Nurses
• Nurse Practitioners
• Pharmacists
• Physician Assistants
• Transplant Coordinators
• Surgeons
• Fellows/Trainees
• Infectious Disease Specialist
• Public Health Workers/Stake Holders
• Epidemiologists
• Virologists 
• Immunologists
• Industry Stakeholders

Continuing Medical Education (CME)

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

CME Credits
Physicians and other health care professionals seeking 7.00 AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Thursday, April 15. The CME evaluation will be available to you upon completion of the live streaming conference.

MOC Points
Physicians seeking ABIM and/or ABP MOC points must complete the CME and MOC evaluation by Thursday, April 15. Requests for MOC after this date will not be honored. The MOC evaluation is included in the CME evaluation.

MOC Points will be reported to the ABIM by the end of October 2021 for attendees who successfully complete the MOC evaluation.

Powered By